The Latest Breaking News on Pharma

Narcotics board 'has no sway' over cannabis orders: Wissanu

The Office of the Narcotics Control Board (ONCB) has no authority to alter or reverse any ministerial announcements signed by Public Health Minister Anutin Charnvirakul concerning the decriminalisation of cannabis, Deputy Prime Minister Wissanu Krea-ngam said on Monday.

Bangkok Post · Nov 21, 2022

More than 6,000 tech and biotech job cuts roil Bay Area economy

Tech and biotech companies have revealed plans recently for enough job cuts to erase more than 6,000 jobs in the Bay Area, cutbacks that could weigh on the region’s economy in the weeks and months to come.

Tribune News Service · Nov 21, 2022

Siriraj Hospital boosts aesthetic treatment safety

Derived from the bacterium Clostridium botulinum, Botulinum toxin type A (BoNT-A) is prescribed for uncontrollable blinking, chronic migraine, overactive bladder and other medical conditions, as well as aesthetic treatments.

Bangkok Post · Nov 21, 2022

Nicola Sturgeon opens 'innovative' rehab service for families impacted by drugs

FIRST Minister Nicola Sturgeon has opened an “innovative” new rehabilitation service which will allow families to stay together while a parent…

The National (Scotland) · Nov 21, 2022

Antibiotic resistance: 150 serious infections occur per day in England

Resistance occurs when bacteria, viruses, fungi and parasites mutate and no longer respond to the medicines designed to treat them.

The Independent UK · Nov 21, 2022

Hidden audits reveal millions in overcharges by Medicare Advantage plans

Taxpayers footed the bill for care that should have cost far less, according to records released under the Freedom of Information Act. The U.S. government may charge insurers $650 million as a result.

WEKU · Nov 21, 2022

Common painkillers can make joint pain worse, new research shows

The study, based on over 1,000 patients, is one of the first to investigate the long term effects

Wales Online · Nov 21, 2022

Gene drug ‘only hope’ for Turkish child, but costs millions

Zolgensma may stop five-year-old Yusuf Polat’s spinal muscular atrophy from progressing, but it costs $2.1m.

Al Jazeera · Nov 21, 2022

Politicians accused of ‘forgetting’ about drug deaths crisis by campaigners

POLITICAL leaders appear to have “forgotten Scotland’s drugs death crisis” campaigners claimed, as they published a report calling for changes…

The National (Scotland) · Nov 21, 2022

Nicola Sturgeon's hollow words not enough to stop drug deaths

The Faces and Voices of Recovery charity says access to rehabilitation and treatment services needs to be made easier

Daily Record · Nov 21, 2022